Management of pregnancy and lactation
Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Sammaritano, Lisa R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
17 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining - 2012transfer abstract, London [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:32 ; year:2018 ; number:6 ; pages:750-766 ; extent:17 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.berh.2019.03.007 |
|---|
| Katalog-ID: |
ELV04760543X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV04760543X | ||
| 003 | DE-627 | ||
| 005 | 20230626020036.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191022s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.berh.2019.03.007 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000719.pica |
| 035 | |a (DE-627)ELV04760543X | ||
| 035 | |a (ELSEVIER)S1521-6942(19)30042-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 690 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 600 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.73 |2 bkl | ||
| 100 | 1 | |a Sammaritano, Lisa R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of pregnancy and lactation |
| 264 | 1 | |c 2018transfer abstract | |
| 300 | |a 17 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. | ||
| 520 | |a Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. | ||
| 650 | 7 | |a Pregnancy |2 Elsevier | |
| 650 | 7 | |a Systemic lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Lactation |2 Elsevier | |
| 650 | 7 | |a Inflammatory arthritis |2 Elsevier | |
| 650 | 7 | |a Rheumatic diseases |2 Elsevier | |
| 650 | 7 | |a Neonatal lupus erythematosus |2 Elsevier | |
| 650 | 7 | |a Antiphospholipid syndrome |2 Elsevier | |
| 700 | 1 | |a Bermas, Bonnie L. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Baillière Tindall |t Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |d 2012transfer abstract |g London [u.a.] |w (DE-627)ELV026205912 |
| 773 | 1 | 8 | |g volume:32 |g year:2018 |g number:6 |g pages:750-766 |g extent:17 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.berh.2019.03.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.73 |j Geomedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 32 |j 2018 |e 6 |h 750-766 |g 17 | ||
| author_variant |
l r s lr lrs |
|---|---|
| matchkey_str |
sammaritanolisarbermasbonniel:2018----:aaeetfrgacad |
| hierarchy_sort_str |
2018transfer abstract |
| bklnumber |
44.73 |
| publishDate |
2018 |
| allfields |
10.1016/j.berh.2019.03.007 doi GBV00000000000719.pica (DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 DE-627 ger DE-627 rakwb eng 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Sammaritano, Lisa R. verfasserin aut Management of pregnancy and lactation 2018transfer abstract 17 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier Bermas, Bonnie L. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:32 year:2018 number:6 pages:750-766 extent:17 https://doi.org/10.1016/j.berh.2019.03.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 32 2018 6 750-766 17 |
| spelling |
10.1016/j.berh.2019.03.007 doi GBV00000000000719.pica (DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 DE-627 ger DE-627 rakwb eng 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Sammaritano, Lisa R. verfasserin aut Management of pregnancy and lactation 2018transfer abstract 17 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier Bermas, Bonnie L. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:32 year:2018 number:6 pages:750-766 extent:17 https://doi.org/10.1016/j.berh.2019.03.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 32 2018 6 750-766 17 |
| allfields_unstemmed |
10.1016/j.berh.2019.03.007 doi GBV00000000000719.pica (DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 DE-627 ger DE-627 rakwb eng 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Sammaritano, Lisa R. verfasserin aut Management of pregnancy and lactation 2018transfer abstract 17 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier Bermas, Bonnie L. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:32 year:2018 number:6 pages:750-766 extent:17 https://doi.org/10.1016/j.berh.2019.03.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 32 2018 6 750-766 17 |
| allfieldsGer |
10.1016/j.berh.2019.03.007 doi GBV00000000000719.pica (DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 DE-627 ger DE-627 rakwb eng 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Sammaritano, Lisa R. verfasserin aut Management of pregnancy and lactation 2018transfer abstract 17 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier Bermas, Bonnie L. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:32 year:2018 number:6 pages:750-766 extent:17 https://doi.org/10.1016/j.berh.2019.03.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 32 2018 6 750-766 17 |
| allfieldsSound |
10.1016/j.berh.2019.03.007 doi GBV00000000000719.pica (DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 DE-627 ger DE-627 rakwb eng 690 VZ 610 VZ 600 VZ 610 VZ 44.73 bkl Sammaritano, Lisa R. verfasserin aut Management of pregnancy and lactation 2018transfer abstract 17 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier Bermas, Bonnie L. oth Enthalten in Baillière Tindall Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining 2012transfer abstract London [u.a.] (DE-627)ELV026205912 volume:32 year:2018 number:6 pages:750-766 extent:17 https://doi.org/10.1016/j.berh.2019.03.007 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.73 Geomedizin VZ AR 32 2018 6 750-766 17 |
| language |
English |
| source |
Enthalten in Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining London [u.a.] volume:32 year:2018 number:6 pages:750-766 extent:17 |
| sourceStr |
Enthalten in Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining London [u.a.] volume:32 year:2018 number:6 pages:750-766 extent:17 |
| format_phy_str_mv |
Article |
| bklname |
Geomedizin |
| institution |
findex.gbv.de |
| topic_facet |
Pregnancy Systemic lupus erythematosus Lactation Inflammatory arthritis Rheumatic diseases Neonatal lupus erythematosus Antiphospholipid syndrome |
| dewey-raw |
690 |
| isfreeaccess_bool |
false |
| container_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| authorswithroles_txt_mv |
Sammaritano, Lisa R. @@aut@@ Bermas, Bonnie L. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV026205912 |
| dewey-sort |
3690 |
| id |
ELV04760543X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04760543X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626020036.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191022s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.berh.2019.03.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000719.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04760543X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1521-6942(19)30042-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sammaritano, Lisa R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Management of pregnancy and lactation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">17</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pregnancy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lactation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory arthritis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rheumatic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neonatal lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antiphospholipid syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bermas, Bonnie L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Baillière Tindall</subfield><subfield code="t">Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV026205912</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:750-766</subfield><subfield code="g">extent:17</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.berh.2019.03.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.73</subfield><subfield code="j">Geomedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2018</subfield><subfield code="e">6</subfield><subfield code="h">750-766</subfield><subfield code="g">17</subfield></datafield></record></collection>
|
| author |
Sammaritano, Lisa R. |
| spellingShingle |
Sammaritano, Lisa R. ddc 690 ddc 610 ddc 600 bkl 44.73 Elsevier Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Management of pregnancy and lactation |
| authorStr |
Sammaritano, Lisa R. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV026205912 |
| format |
electronic Article |
| dewey-ones |
690 - Buildings 610 - Medicine & health 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
690 VZ 610 VZ 600 VZ 44.73 bkl Management of pregnancy and lactation Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome Elsevier |
| topic |
ddc 690 ddc 610 ddc 600 bkl 44.73 Elsevier Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome |
| topic_unstemmed |
ddc 690 ddc 610 ddc 600 bkl 44.73 Elsevier Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome |
| topic_browse |
ddc 690 ddc 610 ddc 600 bkl 44.73 Elsevier Pregnancy Elsevier Systemic lupus erythematosus Elsevier Lactation Elsevier Inflammatory arthritis Elsevier Rheumatic diseases Elsevier Neonatal lupus erythematosus Elsevier Antiphospholipid syndrome |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b l b bl blb |
| hierarchy_parent_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| hierarchy_parent_id |
ELV026205912 |
| dewey-tens |
690 - Building & construction 610 - Medicine & health 600 - Technology |
| hierarchy_top_title |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV026205912 |
| title |
Management of pregnancy and lactation |
| ctrlnum |
(DE-627)ELV04760543X (ELSEVIER)S1521-6942(19)30042-7 |
| title_full |
Management of pregnancy and lactation |
| author_sort |
Sammaritano, Lisa R. |
| journal |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| journalStr |
Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
750 |
| author_browse |
Sammaritano, Lisa R. |
| container_volume |
32 |
| physical |
17 |
| class |
690 VZ 610 VZ 600 VZ 44.73 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sammaritano, Lisa R. |
| doi_str_mv |
10.1016/j.berh.2019.03.007 |
| dewey-full |
690 610 600 |
| title_sort |
management of pregnancy and lactation |
| title_auth |
Management of pregnancy and lactation |
| abstract |
Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. |
| abstractGer |
Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. |
| abstract_unstemmed |
Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
6 |
| title_short |
Management of pregnancy and lactation |
| url |
https://doi.org/10.1016/j.berh.2019.03.007 |
| remote_bool |
true |
| author2 |
Bermas, Bonnie L. |
| author2Str |
Bermas, Bonnie L. |
| ppnlink |
ELV026205912 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.berh.2019.03.007 |
| up_date |
2024-07-06T16:37:28.527Z |
| _version_ |
1803848356758290432 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04760543X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626020036.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191022s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.berh.2019.03.007</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000719.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04760543X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1521-6942(19)30042-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.73</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sammaritano, Lisa R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Management of pregnancy and lactation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">17</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Management of pregnancy in patients with rheumatic and musculoskeletal disorders is both challenging and rewarding. Most patients with rheumatic disease can have a successful pregnancy. Pregnancy outcome is improved when maternal autoimmune disease is stable or quiescent. Prepregnancy evaluation and counseling is important to identify risk factors for adverse maternal and pregnancy outcomes and to guide therapy and monitoring. Severe disease-related damage, disease activity, and the presence of antiphospholipid and anti-Ro/SS-A and La/SS-B antibodies may all impact prognosis. Knowledge of the safety of certain medications during pregnancy and lactation is still incomplete, but an increasing number of effective rheumatic disease medications can be used during these periods with low risk to maintain stable disease and to improve outcomes for mother and child.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pregnancy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Systemic lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lactation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory arthritis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rheumatic diseases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neonatal lupus erythematosus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antiphospholipid syndrome</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bermas, Bonnie L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Baillière Tindall</subfield><subfield code="t">Mercury pollution in Wuchuan mercury mining area, Guizhou, Southwestern China: The impacts from large scale and artisanal mercury mining</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">London [u.a.]</subfield><subfield code="w">(DE-627)ELV026205912</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:750-766</subfield><subfield code="g">extent:17</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.berh.2019.03.007</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.73</subfield><subfield code="j">Geomedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2018</subfield><subfield code="e">6</subfield><subfield code="h">750-766</subfield><subfield code="g">17</subfield></datafield></record></collection>
|
| score |
7.401613 |